EXTENDICARE INC (EXE.CA) Fundamental Analysis & Valuation

TSX:EXE • CA30224T8639

Current stock price

25.56 CAD
+0.16 (+0.63%)
Last:

This EXE.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. EXE.CA Profitability Analysis

1.1 Basic Checks

  • EXE had positive earnings in the past year.
  • In the past year EXE had a positive cash flow from operations.
  • EXE had positive earnings in each of the past 5 years.
  • Each year in the past 5 years EXE had a positive operating cash flow.
EXE.CA Yearly Net Income VS EBIT VS OCF VS FCFEXE.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M -100M 150M

1.2 Ratios

  • EXE has a Return On Assets of 9.06%. This is amongst the best in the industry. EXE outperforms 92.31% of its industry peers.
  • Looking at the Return On Equity, with a value of 25.89%, EXE belongs to the top of the industry, outperforming 92.31% of the companies in the same industry.
  • EXE has a better Return On Invested Capital (14.09%) than 92.31% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for EXE is significantly above the industry average of 7.06%.
Industry RankSector Rank
ROA 9.06%
ROE 25.89%
ROIC 14.09%
ROA(3y)8.19%
ROA(5y)6.95%
ROE(3y)41.67%
ROE(5y)41.08%
ROIC(3y)14.71%
ROIC(5y)10.79%
EXE.CA Yearly ROA, ROE, ROICEXE.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

1.3 Margins

  • Looking at the Profit Margin, with a value of 5.82%, EXE belongs to the top of the industry, outperforming 92.31% of the companies in the same industry.
  • EXE's Profit Margin has improved in the last couple of years.
  • EXE has a Operating Margin of 8.35%. This is in the better half of the industry: EXE outperforms 76.92% of its industry peers.
  • In the last couple of years the Operating Margin of EXE has remained more or less at the same level.
  • EXE has a worse Gross Margin (14.26%) than 76.92% of its industry peers.
  • EXE's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 8.35%
PM (TTM) 5.82%
GM 14.26%
OM growth 3Y57.94%
OM growth 5Y0.49%
PM growth 3Y0.74%
PM growth 5Y4.46%
GM growth 3Y17.09%
GM growth 5Y-1.93%
EXE.CA Yearly Profit, Operating, Gross MarginsEXE.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

7

2. EXE.CA Health Analysis

2.1 Basic Checks

  • EXE has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • Compared to 1 year ago, EXE has more shares outstanding
  • EXE has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for EXE has been reduced compared to a year ago.
EXE.CA Yearly Shares OutstandingEXE.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
EXE.CA Yearly Total Debt VS Total AssetsEXE.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • An Altman-Z score of 3.81 indicates that EXE is not in any danger for bankruptcy at the moment.
  • EXE has a Altman-Z score of 3.81. This is amongst the best in the industry. EXE outperforms 84.62% of its industry peers.
  • EXE has a debt to FCF ratio of 3.18. This is a good value and a sign of high solvency as EXE would need 3.18 years to pay back of all of its debts.
  • EXE has a better Debt to FCF ratio (3.18) than 84.62% of its industry peers.
  • A Debt/Equity ratio of 0.83 indicates that EXE is somewhat dependend on debt financing.
  • EXE has a Debt to Equity ratio of 0.83. This is comparable to the rest of the industry: EXE outperforms 53.85% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.83
Debt/FCF 3.18
Altman-Z 3.81
ROIC/WACC1.92
WACC7.32%
EXE.CA Yearly LT Debt VS Equity VS FCFEXE.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M 300M 400M

2.3 Liquidity

  • EXE has a Current Ratio of 1.37. This is a normal value and indicates that EXE is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of EXE (1.37) is better than 92.31% of its industry peers.
  • EXE has a Quick Ratio of 1.37. This is a normal value and indicates that EXE is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.37, EXE belongs to the top of the industry, outperforming 92.31% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.37
Quick Ratio 1.37
EXE.CA Yearly Current Assets VS Current LiabilitesEXE.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

6

3. EXE.CA Growth Analysis

3.1 Past

  • EXE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 40.99%, which is quite impressive.
  • EXE shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 15.56% yearly.
  • Looking at the last year, EXE shows a quite strong growth in Revenue. The Revenue has grown by 13.25% in the last year.
  • Measured over the past years, EXE shows a small growth in Revenue. The Revenue has been growing by 7.47% on average per year.
EPS 1Y (TTM)40.99%
EPS 3Y12.58%
EPS 5Y15.56%
EPS Q2Q%34.86%
Revenue 1Y (TTM)13.25%
Revenue growth 3Y10.77%
Revenue growth 5Y7.47%
Sales Q2Q%18%

3.2 Future

  • Based on estimates for the next years, EXE will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.39% on average per year.
  • The Revenue is expected to grow by 15.12% on average over the next years. This is quite good.
EPS Next Y8.39%
EPS Next 2Y12.95%
EPS Next 3Y12.39%
EPS Next 5YN/A
Revenue Next Year33.41%
Revenue Next 2Y19.49%
Revenue Next 3Y15.12%
Revenue Next 5YN/A

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EXE.CA Yearly Revenue VS EstimatesEXE.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B 2.5B
EXE.CA Yearly EPS VS EstimatesEXE.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1

4

4. EXE.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 23.03, EXE is valued on the expensive side.
  • 84.62% of the companies in the same industry are more expensive than EXE, based on the Price/Earnings ratio.
  • EXE's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 25.61.
  • EXE is valuated rather expensively with a Price/Forward Earnings ratio of 22.40.
  • 76.92% of the companies in the same industry are more expensive than EXE, based on the Price/Forward Earnings ratio.
  • EXE's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.79.
Industry RankSector Rank
PE 23.03
Fwd PE 22.4
EXE.CA Price Earnings VS Forward Price EarningsEXE.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • 76.92% of the companies in the same industry are more expensive than EXE, based on the Enterprise Value to EBITDA ratio.
  • 61.54% of the companies in the same industry are more expensive than EXE, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 23.29
EV/EBITDA 13.56
EXE.CA Per share dataEXE.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The decent profitability rating of EXE may justify a higher PE ratio.
  • A more expensive valuation may be justified as EXE's earnings are expected to grow with 12.39% in the coming years.
PEG (NY)2.74
PEG (5Y)1.48
EPS Next 2Y12.95%
EPS Next 3Y12.39%

5

5. EXE.CA Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 2.03%, EXE has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 1.41, EXE pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.89, EXE has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.03%

5.2 History

  • The dividend of EXE has a limited annual growth rate of 0.28%.
  • EXE has paid a dividend for at least 10 years, which is a reliable track record.
  • EXE has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)0.28%
Div Incr Years1
Div Non Decr Years3
EXE.CA Yearly Dividends per shareEXE.CA Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

  • 43.14% of the earnings are spent on dividend by EXE. This is a bit on the high side, but may be sustainable.
  • The dividend of EXE is growing, but earnings are growing more, so the dividend growth is sustainable.
DP43.14%
EPS Next 2Y12.95%
EPS Next 3Y12.39%
EXE.CA Yearly Income VS Free CF VS DividendEXE.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M -100M
EXE.CA Dividend Payout.EXE.CA Dividend Payout, showing the Payout Ratio.EXE.CA Dividend Payout.PayoutRetained Earnings

EXE.CA Fundamentals: All Metrics, Ratios and Statistics

EXTENDICARE INC

TSX:EXE (3/25/2026, 7:00:00 PM)

25.56

+0.16 (+0.63%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-26
Earnings (Next)05-04
Inst Owners23.28%
Inst Owner ChangeN/A
Ins Owners0.96%
Ins Owner ChangeN/A
Market Cap2.41B
Revenue(TTM)1.66B
Net Income(TTM)96.66M
Analysts78
Price Target24.43 (-4.42%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.03%
Yearly Dividend0.47
Dividend Growth(5Y)0.28%
DP43.14%
Div Incr Years1
Div Non Decr Years3
Ex-Date02-27
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.07%
PT rev (3m)3.01%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-2.42%
EPS NY rev (3m)-3%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-2.06%
Revenue NY rev (3m)11.58%
Valuation
Industry RankSector Rank
PE 23.03
Fwd PE 22.4
P/S 1.45
P/FCF 23.29
P/OCF 14.76
P/B 6.47
P/tB 13.56
EV/EBITDA 13.56
EPS(TTM)1.11
EY4.34%
EPS(NY)1.14
Fwd EY4.47%
FCF(TTM)1.1
FCFY4.29%
OCF(TTM)1.73
OCFY6.78%
SpS17.58
BVpS3.95
TBVpS1.89
PEG (NY)2.74
PEG (5Y)1.48
Graham Number9.94
Profitability
Industry RankSector Rank
ROA 9.06%
ROE 25.89%
ROCE 18.83%
ROIC 14.09%
ROICexc 26.71%
ROICexgc 53.72%
OM 8.35%
PM (TTM) 5.82%
GM 14.26%
FCFM 6.24%
ROA(3y)8.19%
ROA(5y)6.95%
ROE(3y)41.67%
ROE(5y)41.08%
ROIC(3y)14.71%
ROIC(5y)10.79%
ROICexc(3y)22.22%
ROICexc(5y)15.92%
ROICexgc(3y)39.32%
ROICexgc(5y)26.96%
ROCE(3y)19.66%
ROCE(5y)14.43%
ROICexgc growth 3Y88.69%
ROICexgc growth 5Y25.88%
ROICexc growth 3Y67.25%
ROICexc growth 5Y13.75%
OM growth 3Y57.94%
OM growth 5Y0.49%
PM growth 3Y0.74%
PM growth 5Y4.46%
GM growth 3Y17.09%
GM growth 5Y-1.93%
F-Score6
Asset Turnover1.56
Health
Industry RankSector Rank
Debt/Equity 0.83
Debt/FCF 3.18
Debt/EBITDA 1.77
Cap/Depr 162.15%
Cap/Sales 3.61%
Interest Coverage 12.73
Cash Conversion 93.15%
Profit Quality 107.28%
Current Ratio 1.37
Quick Ratio 1.37
Altman-Z 3.81
F-Score6
WACC7.32%
ROIC/WACC1.92
Cap/Depr(3y)229.86%
Cap/Depr(5y)237.24%
Cap/Sales(3y)5.46%
Cap/Sales(5y)6.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)40.99%
EPS 3Y12.58%
EPS 5Y15.56%
EPS Q2Q%34.86%
EPS Next Y8.39%
EPS Next 2Y12.95%
EPS Next 3Y12.39%
EPS Next 5YN/A
Revenue 1Y (TTM)13.25%
Revenue growth 3Y10.77%
Revenue growth 5Y7.47%
Sales Q2Q%18%
Revenue Next Year33.41%
Revenue Next 2Y19.49%
Revenue Next 3Y15.12%
Revenue Next 5YN/A
EBIT growth 1Y24.69%
EBIT growth 3Y74.95%
EBIT growth 5Y7.99%
EBIT Next Year42.01%
EBIT Next 3Y19.17%
EBIT Next 5YN/A
FCF growth 1Y1.97%
FCF growth 3YN/A
FCF growth 5Y3.29%
OCF growth 1Y13.89%
OCF growth 3Y18.28%
OCF growth 5Y6.16%

EXTENDICARE INC / EXE.CA Fundamental Analysis FAQ

What is the fundamental rating for EXE stock?

ChartMill assigns a fundamental rating of 6 / 10 to EXE.CA.


What is the valuation status for EXE stock?

ChartMill assigns a valuation rating of 4 / 10 to EXTENDICARE INC (EXE.CA). This can be considered as Fairly Valued.


What is the profitability of EXE stock?

EXTENDICARE INC (EXE.CA) has a profitability rating of 7 / 10.


Can you provide the expected EPS growth for EXE stock?

The Earnings per Share (EPS) of EXTENDICARE INC (EXE.CA) is expected to grow by 8.39% in the next year.


Is the dividend of EXTENDICARE INC sustainable?

The dividend rating of EXTENDICARE INC (EXE.CA) is 5 / 10 and the dividend payout ratio is 43.14%.